Zusammenfassung
Hintergrund
Patient*innen mit chronisch-entzündlichen Darmerkrankungen (CED) stellen eine heterogene Gruppe mit unterschiedlichen Symptomen und Komplikationen dar. In Bezug auf die Krankheitsaktivität ist zwischen der Phase des akuten Entzündungsschubs und der Remissionserhaltung zu unterscheiden.
Ziel der Arbeit/Fragestellung
Die vorliegende Arbeit beschreibt die Vorgehensweise und die zu berücksichtigenden Aspekte bei der ernährungstherapeutischen Behandlung von CED-Patient*innen. In Teil 2 dieses Beitrags wird darauf eingegangen, inwieweit Sport- und Bewegungstherapie für diese Patient*innengruppe einen positiven Einfluss auf den Krankheitsverlauf aufweisen können.
Material und Methoden
Die Erfassung des Ernährungszustands wird als Ausgangspunkt der Ernährungstherapie erläutert und anschließend wird die darauf abgestimmte Vorgehensweise zur ernährungstherapeutischen Behandlung in der jeweiligen Krankheitsphase geschildert. Die in den aktuellen Leitlinien vorhandenen Empfehlungen werden unter Berücksichtigung von CED-assoziierten Begleitsymptomen sowie Komplikationen dargestellt.
Ergebnisse und Diskussion
Für CED-Patient*innen ist eine antientzündliche Ernährungsweise auf der Basis einer mediterranen Ernährung empfehlenswert. Dabei stehen für die unterschiedlichen Krankheitsphasen spezifische Ernährungskonzepte zur Verfügung, die im Hinblick auf den individuellen Ernährungszustand anzupassen sind. Das Vorliegen von Mangelzuständen und Begleitsymptomen wie Nahrungsmittelunverträglichkeiten sollte vor Einleitung der Ernährungstherapie diagnostisch abgeklärt werden und die individuelle Behandlung darauf abgestimmt sein.
Abstract
Background
Patients suffering from chronic inflammatory bowel disease (IBD) are a heterogenous patient group with varying symptoms and complications. Concerning disease activity, one has to differentiate between acute flare-ups and remission phases.
Aim
The present publication describes the practice of nutritional therapy in IBD patients, focusing on aspects that have to be considered during this treatment. In addition, the potential positive impact of exercise and physical activity on the course of disease in IBD patients is addressed in part 2 of this article.
Materials and methods
In this publication, we describe how the nutritional status of IBD patients is evaluated at the beginning of the nutritional therapy and how we then proceed with nutritional therapy, based on this evaluation and adapted to the actual disease progress. The recommendations given in the latest guidelines are presented, considering IBD-associated symptoms and complications.
Results and conclusion
We recommend anti-inflammatory nutrition, based on a Mediterranean diet, for IBD patients. Specific nutritional concepts for the respective disease phases have to be adapted to the individual nutritional status of the patient. Diagnosis of nutritional deficiencies, concomitant symptoms, or food intolerances should be checked before starting nutritional therapy. The individual treatment has to consider these results and select appropriate dietetic recommendations for each patient.
Literatur
Anonymous (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5:17–30
Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152:313–321.e2
Bhagavathula AS, Clark CCT, Rahmani J et al (2021) Impact of body mass index on the development of inflammatory bowel disease: a systematic review and dose-response analysis of 15.6 million participants. Healthcare (Basel) 9(1):35
Chen J, Wellens J, Kalla R et al (2022) Intake of ultra-processed foods is associated with an increased risk of Crohn’s disease: a cross-sectional and prospective analysis of 187,154 participants in the UK biobank. J Crohns Colitis 17(4):535–552. https://doi.org/10.1093/ecco-jcc/jjac167
Lopes EW, Chan SSM, Song M et al (2022) Lifestyle factors for the prevention of inflammatory bowel disease. Gut. https://doi.org/10.1136/gutjnl-2022-328174
Aghdassi AA, Allescher H‑D, Andus T et al (2021) Klinische Gastroenterologie. Thieme, Stuttgart
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31
Singh A, Midha V, Mahajan R et al (2023) Evaluation of nutritional characteristics reveals similar prevalence of malnutrition in patients with ulcerative colitis and Crohn’s disease. Dig Dis Sci 68:580–595
Faye AS, Khan T, Cautha S et al (2022) Sarcopenia in inflammatory bowel diseases: reviewing past work to pave the path for the future. Curr Treat Options Gastroenterol 20:250–260
Nishikawa H, Nakamura S, Miyazaki T et al (2021) Inflammatory bowel disease and sarcopenia: its mechanism and clinical importance. J Clin Med 10(18):4214
Aljohani RS, Alaklabi A, Alsitary YM et al (2022) Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience. Ann Saudi Med 42:397–407
Johnson AM, Harmsen WS, Aniwan S et al (2021) Prevalence and impact of obesity on disease-specific outcomes in a population-based cohort of patients with ulcerative colitis. J Crohns Colitis 15:1816–1823
Johnson AM, Harmsen WS, Aniwan S et al (2022) Prevalence and impact of obesity in a population-based cohort of patients with Crohn’s disease. J Clin Gastroenterol. https://doi.org/10.1097/MCG.0000000000001821
Michalak A, Kasztelan-Szczerbińska B, Cichoż-Lach H (2022) Impact of obesity on the course of management of inflammatory bowel disease - a review. Nutrients 14(19):3983
Rowan CR, Mcmanus J, Boland K et al (2021) Visceral adiposity and inflammatory bowel disease. Int J Colorectal Dis 36:2305–2319
Kurnool S, Nguyen NH, Proudfoot J et al (2018) High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis. Aliment Pharmacol Ther 47:1472–1479
Adams DW, Gurwara S, Silver HJ et al (2017) Sarcopenia is common in overweight patients with inflammatory bowel disease and may predict need for surgery. Inflamm Bowel Dis 23:1182–1186
Bryant RV, Schultz CG, Ooi S et al (2018) Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of myopenia and osteopenia. Nutrients 10(9):1192. https://doi.org/10.3390/nu10091192
Bryant RV, Trott MJ, Bartholomeusz FD et al (2013) Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 38:213–225
Liu S, Ding X, Maggiore G et al (2022) Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study. Ann Transl Med 10:367
Liu S, Tian Z, Jiang Y et al (2023) Low muscle mass is associated with readmission for inflammatory bowel disease. Turk J Gastroenterol 34(2):108–117
Mentella MC, Scaldaferri F, Pizzoferrato M et al (2020) Nutrition, IBD and gut microbiota: a review. Nutrients 12(4):944. https://doi.org/10.3390/nu12040944
Cederholm T, Jensen GL, Correia M et al (2019) GLIM criteria for the diagnosis of malnutrition—a consensus report from the global clinical nutrition community. Clin Nutr 38:1–9
Thibault R, Abbasoglu O, Ioannou E et al (2021) ESPEN guideline on hospital nutrition. Clin Nutr 40:5684–5709
Bischoff SC, Bager P, Escher J et al (2023) ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr 42:352–379
Kucharzik T, Dignass A, Atreya R et al (2023) Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) (AWMF-Registriernummer: 021-009)
Sturm A, Atreya R, Bettenworth D et al (2022) Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 60:332–418
Hwang C, Issokson K, Giguere-Rich C et al (2020) Development and pilot testing of the inflammatory bowel disease nutrition care pathway. Clin Gastroenterol Hepatol 18:2645–2649.e4
Wall CL, Wilson B, Lomer MCE (2023) Development and validation of an inflammatory bowel disease nutrition self-screening tool (IBD-NST) for digital use. Front Nutr 10:1065592. https://doi.org/10.3389/fnut.2023.1065592
Fiorindi C, Russo E, Balocchini L et al (2022) Inflammatory bowel disease and customized nutritional intervention focusing on gut microbiome balance. Nutrients 14(19):4117. https://doi.org/10.3390/nu14194117
Haskey N, Peña-Sánchez JN, Jones JL et al (2018) Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease. Asia Pac J Clin Nutr 27:756–762
Li S, Ney M, Eslamparast T et al (2019) Systematic review of nutrition screening and assessment in inflammatory bowel disease. World J Gastroenterol 25:3823–3837
Taylor LM, Eslamparast T, Farhat K et al (2021) Using patient completed screening tools to predict risk of malnutrition in patients with inflammatory bowel disease. Crohns Colitis 360 3(3):otab43. https://doi.org/10.1093/crocol/otab043
Bischoff SC, Barazzoni R, Busetto L et al (2022) European guideline on obesity care in patients with gastrointestinal and liver diseases—joint ESPEN/UEG guideline. Clin Nutr 41:2364–2405
Donini LM, Busetto L, Bischoff SC et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 41:990–1000
Lu Y, Shan Y, Dai L et al (2023) Sex-specific equations to estimate body composition: derivation and validation of diagnostic prediction models using UK biobank. Clin Nutr 42:511–518
Toomey CM, Cremona A, Hughes K et al (2015) A review of body composition measurement in the assessment of health. Top Clin Nutr 30:16–32
Potter AW, Nindl LJ, Soto LD et al (2022) High precision but systematic offset in a standing bioelectrical impedance analysis (BIA) compared with dual-energy X‑ray absorptiometry (DXA). BMJ Nutr Prev Health 5:254–262
Gold SL, Manning L, Kohler D et al (2023) Micronutrients and their role in inflammatory bowel disease: function, assessment, supplementation, and impact on clinical outcomes including muscle health. Inflamm Bowel Dis 29(3):487–501. https://doi.org/10.1093/ibd/izac223
Gold SL, Rabinowitz LG, Manning L et al (2023) High prevalence of malnutrition and micronutrient deficiencies in patients with inflammatory bowel disease early in disease course. Inflamm Bowel Dis 29(3):423–429. https://doi.org/10.1093/ibd/izac102
Balestrieri P, Ribolsi M, Guarino MPL et al (2020) Nutritional aspects in inflammatory bowel diseases. Nutrients 12(2):372. https://doi.org/10.3390/nu12020372
Weisshof R, Chermesh I (2015) Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 18:576–581
Cuerda C, Pironi L, Arends J et al (2021) ESPEN practical guideline: clinical nutrition in chronic intestinal failure. Clin Nutr 40:5196–5220
Blaauw R, Osland E, Sriram K et al (2019) Parenteral provision of micronutrients to adult patients: an expert consensus paper. JPEN J Parenter Enteral Nutr 43(1):S5–S23
Serra-Majem L, Tomaino L, Dernini S et al (2020) Updating the mediterranean diet pyramid towards sustainability: focus on environmental concerns. Int J Environ Res Public Health 17(23):8758. https://doi.org/10.3390/ijerph17238758
Yan J, Wang L, Gu Y et al (2022) Dietary patterns and gut microbiota changes in inflammatory bowel disease: current insights and future challenges. Nutrients 14(19):4003. https://doi.org/10.3390/nu14194003
El Amrousy D, Elashry H, Salamah A et al (2022) Adherence to the mediterranean diet improved clinical scores and inflammatory markers in children with active inflammatory bowel disease: a randomized trial. J Inflamm Res 15:2075–2086
Yılmaz İ, Dolar ME, Özpınar H (2019) Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol 30:242–253
Narula N, Wong ECL, Dehghan M et al (2021) Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 374:n1554
Raoul P, Cintoni M, Palombaro M et al (2022) Food additives, a key environmental factor in the development of IBD through gut dysbiosis. Microorganisms 10(1):167. https://doi.org/10.3390/microorganisms10010167
Rizzello F, Spisni E, Giovanardi E et al (2019) Implications of the westernized diet in the onset and progression of IBD. Nutrients 11(5):1033
Bischoff SC, Escher J, Hébuterne X et al (2020) ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr 39:632–653
Levine A, Rhodes JM, Lindsay JO et al (2020) Dietary guidance from the international organization for the study of inflammatory bowel diseases. Clin Gastroenterol Hepatol 18:1381–1392
Lomer MCE, Wilson B, Wall CL (2023) British dietetic association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease. J Hum Nutr Diet 36:336–377
Yanai H, Levine A, Hirsch A et al (2022) The Crohn’s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn’s disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol 7:49–59
Kucharzik T, Dignass AU, Atreya R et al (2020) Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 58:e241–e326
Cusimano FA, Damas OM (2022) Diet as a treatment for inflammatory bowel disease: is it ready for prime time? Curr Opin Gastroenterol 38:358–372
Limketkai BN, Godoy-Brewer G, Parian AM et al (2022) Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2022.11.026
Wastyk HC, Fragiadakis GK, Perelman D et al (2021) Gut-microbiota-targeted diets modulate human immune status. Cell 184:4137–4153.e14
Gill SK, Rossi M, Bajka B et al (2021) Dietary fibre in gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol 18:101–116
Heseker H, Stahl-Pehe A (2014) Ballaststoffe (Nahrungsfasern). Ernahr Umsch 10:M550–555
Rezende ESV, Lima GC, Naves MMV (2021) Dietary fibers as beneficial microbiota modulators: a proposed classification by prebiotic categories. Nutrition 89:111217
Hauner H, Beyer-Reiners E, Bischoff G et al (2019) Leitfaden Ernährungstherapie in Klinik und Praxis (LEKuP). Aktuel Ernahrungsmed 44:384–419
Ryan DH, Kahan S (2018) Guideline recommendations for obesity management. Med Clin North Am 102:49–63
Wharton S, Lau DCW, Vallis M et al (2020) Obesity in adults: a clinical practice guideline. CMAJ (Ottawa) 192:E875–E891
Kushner RF, Calanna S, Davies M et al (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity (Silver Spring) 28:1050–1061
Friedli N, Odermatt J, Reber E et al (2020) Refeeding syndrome: update and clinical advice for prevention, diagnosis and treatment. Curr Opin Gastroenterol 36:136–140
Friedli N, Stanga Z, Culkin A et al (2018) Management and prevention of refeeding syndrome in medical inpatients: an evidence-based and consensus-supported algorithm. Nutrition 47:13–20
Suskind DL, Cohen SA, Brittnacher MJ et al (2018) Clinical and fecal microbial changes with diet therapy in active inflammatory bowel disease. J Clin Gastroenterol 52:155–163
Gill PA, Inniss S, Kumagai T et al (2022) The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front Immunol 13:866059
Olendzki BC, Silverstein TD, Persuitte GM et al (2014) An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J 13:5
Olendzki B, Bucci V, Cawley C et al (2022) Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: pilot study. Gut Microbes 14:2046244
Levine A, Wine E, Assa A et al (2019) Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology 157:440–450.e8
Sigall-Boneh R, Pfeffer-Gik T, Segal I et al (2014) Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. Inflamm Bowel Dis 20:1353–1360
Campmans-Kuijpers MJE, Dijkstra G (2021) Food and food groups in inflammatory bowel disease (IBD): the design of the Groningen anti-inflammatory diet (GrAID). Nutrients 13(4):1067. https://doi.org/10.3390/nu13041067
Barrett JS, Irving PM, Shepherd SJ et al (2009) Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 30:165–174
Helwig U, Koch AK, Reichel C et al (2021) A prospective multicenter study on the prevalence of fructose malabsorption in patients with chronic inflammatory bowel disease. Digestion 102:397–403
Herz D, Weber L, Herrmann JH, Zopf Y (2023) Lifestyle im Management chronisch-entzündlicher Darmerkrankungen – Teil 2: Sport. Gastroenterol. https://doi.org/10.1007/s11377-023-00705-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
L. Weber, W. Dieterich, H. J. Herrmann und Y. Zopf geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Jörg Bojunga, Frankfurt am Main
Mathias Plauth, Dessau-Roßlau
Christian Trautwein, Aachen
Hinweis
Den Beitrag „Lifestyle im Management chronisch-entzündlicher Darmerkrankungen – Teil 2: Sport“ finden Sie in Ausgabe 4/2023 von Die Gastroenterologie oder online unter https://doi.org/10.1007/s11377-023-00705-3.
English text corrected by: M. Gossen
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Weber, L., Dieterich, W., Herrmann, H.J. et al. Lifestyle im Management chronisch-entzündlicher Darmerkrankungen – Teil 1: Ernährung. Gastroenterologie 18, 255–269 (2023). https://doi.org/10.1007/s11377-023-00704-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-023-00704-4
Schlüsselwörter
- Chronische Darmentzündung
- Ernährungstherapie
- Mediterrane Ernährung
- Individualisierte Medizin
- Ernährungszustand